Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:6:p12
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 6 (pt 12/36)
Character Range: 342146–345118

with the warnings:

          (i) KEEP OUT OF REACH OF CHILDREN; and

          (ii) NOT TO BE TAKEN; or

       (e) in preparations containing 25% or less of cineole; or

       (f) in oils containing 25% or less of cineole; or

       (g) in rosemary oil or camphor oil (white).
    CINNAMON LEAF OIL except:

       (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or

       (b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or

       (c) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:

          (i) KEEP OUT OF REACH OF CHILDREN; and

          (ii) NOT TO BE TAKEN; or

       (d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and labelled with the warnings:

          (i) KEEP OUT OF REACH OF CHILDREN; and

          (ii) NOT TO BE TAKEN; or

       (e) in preparations containing 25% or less of cinnamon leaf oil.
    CLIMBAZOLE except:

       (a) when included in Schedule 5; or

       (b) in leave‑on hair, face and foot cosmetic preparations containing 0.5% or less of climbazole; or

       (c) in other preparations (that are not leave‑on cosmetic preparations) containing 2% or less of climbazole.
    CLODINAFOP‑PROPARGYL.
    CLOMAZONE.
    CLOSANTEL.
    CLOTHIANIDIN except

       (a) when included in Schedule 5; or

       (b) when in gel preparations dispensed in sealed cartridges containing 1% or less of clothianidin.
    CLOTRIMAZOLE for the external treatment of animals.
    CLOVE OIL except:

       (a) when included in Schedule 5; or

       (b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or

       (c) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or

       (d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:

          (i) KEEP OUT